Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors

During the last decades, further knowledge of hepatocellular carcinoma (HCC) molecular mechanisms has led to development of effective systemic treatments including tyrosine kinase inhibitors (TKIs) and immunotherapy. In this review, we describe first and second line systemic treatment options for ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñero, Federico, Silva, Marcelo, Iavarone, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201145/
https://www.ncbi.nlm.nih.gov/pubmed/32390700
http://dx.doi.org/10.3748/wjg.v26.i16.1888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201145/
https://www.ncbi.nlm.nih.gov/pubmed/32390700
http://dx.doi.org/10.3748/wjg.v26.i16.1888

Ejemplares similares